Iron-Gallic Acid Peptide Nanoparticles as a Versatile Platform for Cellular Delivery with Synergistic ROS Enhancement Effect

Cytosolic delivery of peptides is of great interest owing to their biological functions, which could be utilized for therapeutic applications. However, their susceptibility to enzymatic degradation and multiple cellular barriers generally hinders their clinical application. Integration into nanopart...

Full description

Bibliographic Details
Main Authors: Faqian Shen, Yi Lin, Miriam Höhn, Xianjin Luo, Markus Döblinger, Ernst Wagner, Ulrich Lächelt
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/7/1789
_version_ 1797587767885037568
author Faqian Shen
Yi Lin
Miriam Höhn
Xianjin Luo
Markus Döblinger
Ernst Wagner
Ulrich Lächelt
author_facet Faqian Shen
Yi Lin
Miriam Höhn
Xianjin Luo
Markus Döblinger
Ernst Wagner
Ulrich Lächelt
author_sort Faqian Shen
collection DOAJ
description Cytosolic delivery of peptides is of great interest owing to their biological functions, which could be utilized for therapeutic applications. However, their susceptibility to enzymatic degradation and multiple cellular barriers generally hinders their clinical application. Integration into nanoparticles, which can enhance the stability and membrane permeability of bioactive peptides, is a promising strategy to overcome extracellular and intracellular obstacles. Herein, we present a versatile platform for the cellular delivery of various cargo peptides by integration into metallo-peptidic coordination nanoparticles. Both termini of cargo peptides were conjugated with gallic acid (GA) to assemble GA-modified peptides into nanostructures upon coordination of Fe(III). Initial pre-complexation of Fe(III) by poly-(vinylpolypyrrolidon) (PVP) as a template favored the formation of nanoparticles, which are able to deliver the peptides into cells efficiently. Iron–gallic acid peptide nanoparticles (IGPNs) are stable in water and are supposed to generate reactive oxygen species (ROS) from endogenous H<sub>2</sub>O<sub>2</sub> in cells via the Fenton reaction. The strategy was successfully applied to an exemplary set of peptide sequences varying in length (1–7 amino acids) and charge (negative, neutral, positive). To confirm the capability of transporting bioactive cargos into cells, pro-apoptotic peptides were integrated into IGPNs, which demonstrated potent killing of human cervix carcinoma HeLa and murine neuroblastoma N2a cells at a 10 µM peptide concentration via the complementary mechanisms of peptide-triggered apoptosis and Fe(III)-mediated ROS generation. This study demonstrates the establishment of IGPNs as a novel and versatile platform for the assembly of peptides into nanoparticles, which can be used for cellular delivery of bioactive peptides combined with intrinsic ROS generation.
first_indexed 2024-03-11T00:44:32Z
format Article
id doaj.art-08b0fcc148874fb285f810a31685af30
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-11T00:44:32Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-08b0fcc148874fb285f810a31685af302023-11-18T20:53:52ZengMDPI AGPharmaceutics1999-49232023-06-01157178910.3390/pharmaceutics15071789Iron-Gallic Acid Peptide Nanoparticles as a Versatile Platform for Cellular Delivery with Synergistic ROS Enhancement EffectFaqian Shen0Yi Lin1Miriam Höhn2Xianjin Luo3Markus Döblinger4Ernst Wagner5Ulrich Lächelt6Pharmaceutical Biotechnology, Department of Pharmacy, Center for NanoScience (CeNS), LMU Munich, 81377 Munich, GermanyPharmaceutical Biotechnology, Department of Pharmacy, Center for NanoScience (CeNS), LMU Munich, 81377 Munich, GermanyPharmaceutical Biotechnology, Department of Pharmacy, Center for NanoScience (CeNS), LMU Munich, 81377 Munich, GermanyPharmaceutical Biotechnology, Department of Pharmacy, Center for NanoScience (CeNS), LMU Munich, 81377 Munich, GermanyDepartment of Chemistry, LMU Munich, 81377 Munich, GermanyPharmaceutical Biotechnology, Department of Pharmacy, Center for NanoScience (CeNS), LMU Munich, 81377 Munich, GermanyPharmaceutical Biotechnology, Department of Pharmacy, Center for NanoScience (CeNS), LMU Munich, 81377 Munich, GermanyCytosolic delivery of peptides is of great interest owing to their biological functions, which could be utilized for therapeutic applications. However, their susceptibility to enzymatic degradation and multiple cellular barriers generally hinders their clinical application. Integration into nanoparticles, which can enhance the stability and membrane permeability of bioactive peptides, is a promising strategy to overcome extracellular and intracellular obstacles. Herein, we present a versatile platform for the cellular delivery of various cargo peptides by integration into metallo-peptidic coordination nanoparticles. Both termini of cargo peptides were conjugated with gallic acid (GA) to assemble GA-modified peptides into nanostructures upon coordination of Fe(III). Initial pre-complexation of Fe(III) by poly-(vinylpolypyrrolidon) (PVP) as a template favored the formation of nanoparticles, which are able to deliver the peptides into cells efficiently. Iron–gallic acid peptide nanoparticles (IGPNs) are stable in water and are supposed to generate reactive oxygen species (ROS) from endogenous H<sub>2</sub>O<sub>2</sub> in cells via the Fenton reaction. The strategy was successfully applied to an exemplary set of peptide sequences varying in length (1–7 amino acids) and charge (negative, neutral, positive). To confirm the capability of transporting bioactive cargos into cells, pro-apoptotic peptides were integrated into IGPNs, which demonstrated potent killing of human cervix carcinoma HeLa and murine neuroblastoma N2a cells at a 10 µM peptide concentration via the complementary mechanisms of peptide-triggered apoptosis and Fe(III)-mediated ROS generation. This study demonstrates the establishment of IGPNs as a novel and versatile platform for the assembly of peptides into nanoparticles, which can be used for cellular delivery of bioactive peptides combined with intrinsic ROS generation.https://www.mdpi.com/1999-4923/15/7/1789intracellular deliverypeptide therapeuticscoordination nanoparticlesROStumor combination therapy
spellingShingle Faqian Shen
Yi Lin
Miriam Höhn
Xianjin Luo
Markus Döblinger
Ernst Wagner
Ulrich Lächelt
Iron-Gallic Acid Peptide Nanoparticles as a Versatile Platform for Cellular Delivery with Synergistic ROS Enhancement Effect
Pharmaceutics
intracellular delivery
peptide therapeutics
coordination nanoparticles
ROS
tumor combination therapy
title Iron-Gallic Acid Peptide Nanoparticles as a Versatile Platform for Cellular Delivery with Synergistic ROS Enhancement Effect
title_full Iron-Gallic Acid Peptide Nanoparticles as a Versatile Platform for Cellular Delivery with Synergistic ROS Enhancement Effect
title_fullStr Iron-Gallic Acid Peptide Nanoparticles as a Versatile Platform for Cellular Delivery with Synergistic ROS Enhancement Effect
title_full_unstemmed Iron-Gallic Acid Peptide Nanoparticles as a Versatile Platform for Cellular Delivery with Synergistic ROS Enhancement Effect
title_short Iron-Gallic Acid Peptide Nanoparticles as a Versatile Platform for Cellular Delivery with Synergistic ROS Enhancement Effect
title_sort iron gallic acid peptide nanoparticles as a versatile platform for cellular delivery with synergistic ros enhancement effect
topic intracellular delivery
peptide therapeutics
coordination nanoparticles
ROS
tumor combination therapy
url https://www.mdpi.com/1999-4923/15/7/1789
work_keys_str_mv AT faqianshen irongallicacidpeptidenanoparticlesasaversatileplatformforcellulardeliverywithsynergisticrosenhancementeffect
AT yilin irongallicacidpeptidenanoparticlesasaversatileplatformforcellulardeliverywithsynergisticrosenhancementeffect
AT miriamhohn irongallicacidpeptidenanoparticlesasaversatileplatformforcellulardeliverywithsynergisticrosenhancementeffect
AT xianjinluo irongallicacidpeptidenanoparticlesasaversatileplatformforcellulardeliverywithsynergisticrosenhancementeffect
AT markusdoblinger irongallicacidpeptidenanoparticlesasaversatileplatformforcellulardeliverywithsynergisticrosenhancementeffect
AT ernstwagner irongallicacidpeptidenanoparticlesasaversatileplatformforcellulardeliverywithsynergisticrosenhancementeffect
AT ulrichlachelt irongallicacidpeptidenanoparticlesasaversatileplatformforcellulardeliverywithsynergisticrosenhancementeffect